Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 61
Filter
1.
J Cosmet Laser Ther ; 21(2): 71-75, 2019.
Article in English | MEDLINE | ID: mdl-29764244

ABSTRACT

INTRODUCTION: Fractionated radiofrequency (RF) tissue tightening is an alternative method to fractionated laser treatment of skin wrinkling, laxity and acne scars, with reduced risk of scarring or persistent pigmentation. The aim of this study was to evaluate and quantify the wound healing process after RF treatment. MATERIALS AND METHODS: 12 patients were treated with a 64-pin fractional bipolar RF device with 60 mJ/pin applied energy. Confocal laser scanning microscopy (CLSM) examination was performed on day 1, day 2, day 7 and day 14 after treatment. Clinical wound healing process was measured and expressed as a percentage. RESULTS: All patients developed erythema, mild edema and crusts at the treated areas. Two weeks after treatment clinical symptoms resolved. During ablation patients reported moderate pain. Directly after ablation microscopic ablation zones could be detected in CLSM. Measurement of MAZ at epidermis, dermo-epidermal junction and papilary dermis showed a constant diameter until two weeks after treatment. Re-epithelization of the MAZ could be detected already 1 week after treatment. However, 2 weeks after ablation the honeycomb pattern of the epidermis was not yet completely restored. DISCUSSION: Bipolar fractionated RF treatment demonstrates clinically a rapid wound healing response. The subepidermal remodelling process still ongoing after 14 days, showing new granulation tissue. Therefore, treatment intervals of at least 14 days should be recommended to allow completion of the remodelling process.


Subject(s)
Radiofrequency Therapy , Skin Aging/radiation effects , Wound Healing/radiation effects , Adult , Cosmetic Techniques/adverse effects , Erythema/etiology , Female , Humans , Male , Microscopy, Confocal , Pain/etiology , Radio Waves/adverse effects , Wound Healing/physiology
2.
J Eur Acad Dermatol Venereol ; 29(12): 2405-10, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26416154

ABSTRACT

BACKGROUND: Facial redness contributes to impaired psychosocial functioning in rosacea patients and the only approved treatment for erythema is topical brimonidine gel 0.33%. OBJECTIVES: To evaluate patient-reported outcomes, as well as efficacy and safety, in subjects with self-perceived severe erythema treated with brimonidine gel 0.33% compared to vehicle. METHODS: An 8-day multicenter, randomized study comparing once-daily brimonidine gel 0.33% with vehicle gel using a facial redness questionnaire, subject satisfaction questionnaire and a patient diary of facial redness control to assess patient-reported outcomes. RESULTS: Of the 92 included subjects with self-perceived severe erythema, very few were satisfied with their appearance at baseline (4.2% brimonidine group, 0 vehicle group). On Day 8, significantly more brimonidine group subjects were satisfied with their facial appearance compared to vehicle group (36.9% vs. 21.5%; P < 0.05), with the overall treatment effect (69.6% vs. 40.4%; P < 0.01), and with the improvement in their facial redness (67.4% vs. 33.3%; P < 0.001). More brimonidine group subjects were able to control their facial redness daily (e.g. 83.0% vs. 38.9% on Day 1). On Day 8, significantly more brimonidine group subjects than vehicle group had at least a one-grade improvement from baseline in the Clinician Erythema Assessment score (71.7% vs. 35.7%; P = 0.0011) and Patient Self-Assessment score (76.1% vs. 47.6%; P = 0.004). More subjects in the brimonidine group (29.2%) reported treatment-related adverse events than in the vehicle group (15.9%) but most were mild and transient. CONCLUSIONS: Once-daily brimonidine gel 0.33% allowed patients to rapidly control their facial redness and significantly improved patient-reported outcomes in the treatment of persistent facial erythema of rosacea.


Subject(s)
Adrenergic alpha-2 Receptor Agonists/therapeutic use , Brimonidine Tartrate/therapeutic use , Erythema/drug therapy , Facial Dermatoses/drug therapy , Rosacea/complications , Adrenergic alpha-2 Receptor Agonists/adverse effects , Adult , Aged , Brimonidine Tartrate/adverse effects , Erythema/etiology , Female , Gels , Humans , Male , Middle Aged , Patient Satisfaction , Severity of Illness Index , Surveys and Questionnaires , Treatment Outcome , Young Adult
3.
Skin Pharmacol Physiol ; 27 Suppl 1: 18-25, 2014.
Article in English | MEDLINE | ID: mdl-24280645

ABSTRACT

Acne, one of the most common skin problems in dermatological practice, is a condition that affects not only adolescents but also adults. While approximately 80% of cases occurring in adulthood are persistent from teenage years, around 20% are described as 'late-onset' disease, appearing for the first time in adulthood. The disease can be triggered by hormonal changes (including a change from one contraceptive to another), or it can be induced by certain nonhormonal medications, emotional stress, and various underlying diseases such as polycystic ovary syndrome. In many cases acne becomes a chronic skin condition with undulating activity, including improvement and relapse phases, and is often experienced as a major psychological burden. It is, therefore, even more important to provide an effective as well as a safe and tolerable treatment. The spectrum of topical acne treatments has expanded substantially in recent years and various topical medications are available, ranging from azelaic acid, antibiotics, retinoids and benzoyl peroxide to several fixed combinations of these active compounds. The following case collection illustrates how 15% azelaic acid gel, as a well-established monotherapy, can be successfully employed to treat mild-to-moderate forms of adult female acne.


Subject(s)
Acne Vulgaris/drug therapy , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Dermatologic Agents/therapeutic use , Dicarboxylic Acids/therapeutic use , Adult , Female , Humans , Young Adult
4.
Vet Microbiol ; 162(2-4): 437-446, 2013 Mar 23.
Article in English | MEDLINE | ID: mdl-23238022

ABSTRACT

Currently no live DIVA (Differentiating Infected from Vaccinated Animals) vaccines against classical swine fever (CSF) are available. The aim of this study was to investigate whether chimeric pestivirus vaccine candidates (CP7_E2alf, Flc11 and Flc9) are able to protect pigs against clinical signs, and to reduce virus shedding and virus transmission, after a challenge with CSF virus (CSFV), 7 or 14 days after a single intramuscular vaccination. In these vaccine candidates, either the E2 or the E(rns) encoding genome region of a bovine viral diarrhoea virus strain were combined with a cDNA copy of CSFV or vice versa. Furthermore, currently available serological DIVA tests were evaluated. The vaccine candidates were compared to the C-strain. All vaccine candidates protected against clinical signs. No transmission to contact pigs was detected in the groups vaccinated with C-strain, CP7_E2alf and Flc11. Limited transmission occurred in the groups vaccinated with Flc9. All vaccine candidates would be suitable to stop on-going transmission of CSFV. For Flc11, no reliable differentiation was possible with the current E(rns)-based DIVA test. For CP7_E2alf, the distribution of the inhibition percentages was such that up to 5% false positive results may be obtained in a large vaccinated population. For Flc9 vaccinated pigs, the E2 ELISA performed very well, with an expected 0.04% false positive results in a large vaccinated population. Both CP7_E2alf and Flc9 are promising candidates to be used as live attenuated marker vaccines against CSF, with protection the best feature of CP7_E2alf, and the DIVA principle the best feature of Flc9.


Subject(s)
Classical Swine Fever Virus/immunology , Classical Swine Fever/therapy , Pestivirus/immunology , Viral Vaccines/therapeutic use , Animals , Antibodies, Viral/immunology , Classical Swine Fever/immunology , Classical Swine Fever/prevention & control , Classical Swine Fever/virology , Classical Swine Fever Virus/genetics , Enzyme-Linked Immunosorbent Assay , Injections, Intramuscular , Palatine Tonsil/virology , Pestivirus/genetics , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Sus scrofa , Swine , Vaccination/veterinary , Vaccines, Attenuated/immunology , Vaccines, Attenuated/therapeutic use , Viral Vaccines/immunology , Virus Shedding
8.
Cell Mol Life Sci ; 59(7): 1117-28, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12222959

ABSTRACT

Receptor for AGE (RAGE) is a member of the immunoglobulin superfamily that engages distinct classes of ligands. The biology of RAGE is driven by the settings in which these ligands accumulate, such as diabetes, inflammation, neurodegenerative disorders and tumors. In this review, we discuss the context of each of these classes of ligands, including advance glycation end-products, amyloid beta peptide and the family of beta sheet fibrils, S100/calgranulins and amphoterin. Implications for the role of these ligands interacting with RAGE in homeostasis and disease will be considered.


Subject(s)
Receptors, Immunologic/physiology , Alzheimer Disease/etiology , Amyloidosis/etiology , Animals , Arteriosclerosis/etiology , Arteriosclerosis/metabolism , Arteriosclerosis/pathology , Cell Movement , Chronic Disease , Diabetic Angiopathies/etiology , Diabetic Angiopathies/metabolism , Diabetic Angiopathies/pathology , Homeostasis , Humans , Immunoglobulins/classification , Inflammation/etiology , Mice , Neoplasms/etiology , Neoplasms/pathology , Receptor for Advanced Glycation End Products , Receptors, Immunologic/metabolism , Signal Transduction
9.
Genes Immun ; 3(3): 123-35, 2002 May.
Article in English | MEDLINE | ID: mdl-12070776

ABSTRACT

The receptor for advanced glycation end products (RAGE) and its proinflammatory S100/calgranulin ligands are enriched in joints of subjects with rheumatoid arthritis (RA) and amplify the immune/inflammatory response. In a model of inflammatory arthritis, blockade of RAGE in mice immunized and challenged with bovine type II collagen suppressed clinical and histologic evidence of arthritis, in parallel with diminished levels of TNF-alpha, IL-6, and matrix metalloproteinases (MMP) 3, 9 and 13 in affected tissues. Allelic variation within key domains of RAGE may influence these proinflammatory mechanisms, thereby predisposing individuals to heightened inflammatory responses. A polymorphism of the RAGE gene within the ligand-binding domain of the receptor has been identified, consisting of a glycine to serine change at position 82. Cells bearing the RAGE 82S allele displayed enhanced binding and cytokine/MMP generation following ligation by a prototypic S100/calgranulin compared with cells expressing the RAGE 82G allele. In human subjects, a case-control study demonstrated an increased prevalence of the 82S allele in patients with RA compared with control subjects. These data suggest that RAGE 82S upregulates the inflammatory response upon engagement of S100/calgranulins, and, thereby, may contribute to enhanced proinflammatory mechanisms in immune/inflammatory diseases.


Subject(s)
Arthritis, Rheumatoid/genetics , Polymorphism, Genetic , Receptors, Immunologic/genetics , Alleles , Animals , Arthritis, Experimental/immunology , Arthritis, Rheumatoid/metabolism , Arthritis, Rheumatoid/pathology , CHO Cells , Cricetinae , Humans , Leukocyte L1 Antigen Complex/genetics , Leukocyte L1 Antigen Complex/metabolism , Male , Mice , Mice, Inbred DBA , Receptor for Advanced Glycation End Products , Receptors, Immunologic/metabolism
10.
Virus Genes ; 23(1): 63-8, 2001.
Article in English | MEDLINE | ID: mdl-11556403

ABSTRACT

Based on an infectious cDNA clone of classical swine fever virus (CSFV) strain Alfort/187 (Ruggli et al., J Virol 70, 3478-3487, 1996) a full-length cDNA was constructed harbouring a nonviral 44 base insertion in the internal ribosome entry site (IRES) within the 5' nontranslated region (5'NTR) of the genome. Genome size RNA transcribed in vitro served as a positive control in routine RT-PCR used to detect CSFV RNA in diagnostic material. Unexpectedly this RNA proved to be infectious upon transfection into susceptible cells. The replication kinetics of the resulting virus vA187-Ins44 were characterized and found to be indistinguishable from its parent virus. However, a deletion mutant with 29 of the 44 inserted bases missing was detected after multiple cell culture passages. RNA secondary structure analysis of the 5'NTR showed that the 44 base insertion destroyed a stem-loop structure and a pseudoknot previously described to be essential for virus replication, demonstrating that insertions within this functionally essential IRES element are tolerated by CSFV.


Subject(s)
5' Untranslated Regions , Classical Swine Fever Virus/genetics , RNA, Viral , Ribosomes/metabolism , 5' Untranslated Regions/chemistry , Animals , Base Sequence , Binding Sites , Cell Line , Classical Swine Fever Virus/pathogenicity , Classical Swine Fever Virus/physiology , DNA, Viral , Genetic Markers , Molecular Sequence Data , Mutagenesis, Site-Directed , Nucleic Acid Conformation , RNA, Viral/chemistry , Recombination, Genetic , Swine
11.
J Virol Methods ; 98(1): 63-75, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11543885

ABSTRACT

Since two different types of porcine reproductive and respiratory syndrome virus (PRRSV), the European (EU) and the North American (US) strain, occur or coexist in European swine herds, their rapid and reliable detection and differentiation is essential for disease surveillance. A quantitative TaqMan reverse transcription-polymerase chain reaction (RT-PCR) is described for PRRSV detection and strain differentiation. Sensitivity and specificity were compared with a conventional PRRSV RT-PCR and to the detection of both PRRSV types in cell cultures and both were found to be equal or superior to the reference methods. Reproducibility was tested and proved that the assay was very reliable. Standard dilutions included in each test allowed absolute quantitation of the amount of viral RNA. The TaqMan assay described below is time-saving, easy to handle, exhibits a decreased risk of cross-contamination and is highly sensitive and specific. It is, therefore, considered to be a powerful tool for the rapid detection and differentiation of PRRSV.


Subject(s)
Porcine respiratory and reproductive syndrome virus/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Swine/virology , Animals , Europe , Fluorescent Dyes , North America , Polymerase Chain Reaction/methods , Porcine Reproductive and Respiratory Syndrome/diagnosis , Porcine respiratory and reproductive syndrome virus/classification , Porcine respiratory and reproductive syndrome virus/genetics , RNA, Viral/analysis , Reproducibility of Results , Sensitivity and Specificity , Taq Polymerase
12.
Arterioscler Thromb Vasc Biol ; 21(6): 905-10, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11397695

ABSTRACT

Advanced glycation end products (AGEs) and their cell surface receptor, RAGE, have been implicated in the pathogenesis of diabetic complications. Here, we studied the role of RAGE and expression of its proinflammatory ligands, EN-RAGEs (S100/calgranulins), in inflammatory events mediating cellular activation in diabetic tissue. Apolipoprotein E-null mice were rendered diabetic with streptozotocin at 6 weeks of age. Compared with nondiabetic aortas and kidneys, diabetic aortas and kidneys displayed increased expression of RAGE, EN-RAGEs, and 2 key markers of vascular inflammation, vascular cell adhesion molecule (VCAM)-1 and tissue factor. Administration of soluble RAGE, the extracellular domain of the receptor, or vehicle to diabetic mice for 6 weeks suppressed levels of VCAM-1 and tissue factor in the aorta, in parallel with decreased expression of RAGE and EN-RAGEs. Diabetic kidney demonstrated increased numbers of EN-RAGE-expressing inflammatory cells infiltrating the glomerulus and enhanced mRNA for transforming growth factor-beta, fibronectin, and alpha(1) (IV) collagen. In mice treated with soluble RAGE, the numbers of infiltrating inflammatory cells and mRNA levels for these glomerular cytokines and components of extracellular matrix were decreased. These data suggest that activation of RAGE primes cells targeted for perturbation in diabetic tissues by the induction of proinflammatory mediators.


Subject(s)
Apolipoproteins E/genetics , Diabetes Mellitus, Experimental/complications , Receptors, Immunologic/physiology , Thromboplastin/biosynthesis , Vasculitis/metabolism , Animals , Aorta/metabolism , Kidney/metabolism , Leukocyte L1 Antigen Complex , Male , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , NF-kappa B/metabolism , Neural Cell Adhesion Molecules/metabolism , Receptor for Advanced Glycation End Products , Vascular Cell Adhesion Molecule-1/metabolism , Vasculitis/complications
13.
J Clin Invest ; 107(6): 675-83, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11254667

ABSTRACT

Although hyperhomocysteinemia (HHcy) is a well-known risk factor for the development of cardiovascular disease, the underlying molecular mechanisms are not fully elucidated. Here we show that induction of HHcy in apoE-null mice by a diet enriched in methionine but depleted in folate and vitamins B6 and B12 increased atherosclerotic lesion area and complexity, and enhanced expression of receptor for advanced glycation end products (RAGE), VCAM-1, tissue factor, and MMP-9 in the vasculature. These homocysteine-mediated (HC-mediated) effects were significantly suppressed, in parallel with decreased levels of plasma HC, upon dietary supplementation with folate and vitamins B6/B12. These findings implicate HHcy in atherosclerotic plaque progression and stability, and they suggest that dietary enrichment in vitamins essential for the metabolism of HC may impart protective effects in the vasculature.


Subject(s)
Arteriosclerosis/etiology , Hyperhomocysteinemia/complications , Vasculitis/etiology , Animals , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Arteriosclerosis/metabolism , Arteriosclerosis/pathology , Cells, Cultured , Diet , Disease Models, Animal , Folic Acid/administration & dosage , Humans , Hyperhomocysteinemia/metabolism , Immunohistochemistry , Male , Matrix Metalloproteinase 9/metabolism , Methionine/administration & dosage , Mice , Mice, Inbred C57BL , Mice, Knockout , Pyridoxine/administration & dosage , Receptor for Advanced Glycation End Products , Receptors, Immunologic/metabolism , Thromboplastin/metabolism , Vascular Cell Adhesion Molecule-1/metabolism , Vasculitis/metabolism , Vasculitis/pathology , Vitamin B 12/administration & dosage
14.
Vet Microbiol ; 74(4): 293-308, 2000 Jun 12.
Article in English | MEDLINE | ID: mdl-10831853

ABSTRACT

To study the replication of classical swine fever virus (CSFV) in cell culture, kinetics of viral plus-strand RNA synthesis, of viral structural and non-structural protein expression as well as of secreted and cell-associated infectious virus were determined. Highly virulent, moderately virulent and avirulent strains that were tested in standardized animal experiments to confirm their virulence were used to search for in vitro parameters allowing the differentiation of strains according to their virulence. No significant qualitative or quantitative differences were found between the strains studied when either RNA replication or protein synthesis were investigated. However, the ratio of cell-associated virus versus secreted virus proved to be considerably lower for the highly virulent strains when compared to avirulent or moderately virulent strains. These data suggest that highly virulent strains of CSFV can be distinguished in cell culture from strains with reduced virulence.


Subject(s)
Classical Swine Fever Virus/classification , Classical Swine Fever/virology , Virus Replication/physiology , Animals , Blotting, Northern/veterinary , Blotting, Western/veterinary , Body Temperature , Cell Line , Classical Swine Fever Virus/pathogenicity , Classical Swine Fever Virus/physiology , Enzyme-Linked Immunosorbent Assay/veterinary , Immunoenzyme Techniques/veterinary , Kinetics , RNA, Viral/chemistry , RNA, Viral/isolation & purification , Specific Pathogen-Free Organisms , Swine , Viral Proteins/biosynthesis , Virulence
15.
J Virol Methods ; 87(1-2): 29-39, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10856750

ABSTRACT

A method for storing samples containing classical swine fever virus (CSFV) or foot-and-mouth disease virus (FMDV), respectively, was developed, which abolishes the infectivity of both plus strand RNA viruses, and allows storage of samples above 0 degrees C for an extended time, yet preserves the viral RNA in a state which allows its detection by reverse transcription-polymerase chain reaction (RT-PCR), and even rescue of infectious virus after transfection of the extracted RNA into susceptible cells. Supernatants from infected cell cultures as well as organs from diseased animals were stored in Trizol(R) for 1-4 weeks at -20 degrees C, 4 degrees C, room temperature, or 37 degrees C. RNA was then extracted and used subsequently for RT-PCR, as well as transfection into susceptible cells to initiate the replication of progeny virus. Formaldehyde-fixed samples were also included in this study. Storage up to 4 weeks at 37 degrees C in Trizol(R) still yielded positive RT-PCR results and rescue of infectious virus upon RNA transfection. In contrast, formaldehyde fixation reduced drastically the detectability of viral RNA. This method represents a safe and inexpensive alternative to -70 degrees C (dry ice) storage or transport of samples, and abolishes the biosafety risks involved in shipping deep-frozen infectious materials.


Subject(s)
Classical Swine Fever/virology , Foot-and-Mouth Disease/virology , Guanidines , Microbiological Techniques , Phenols , Animals , Cell Line , Classical Swine Fever Virus/genetics , Classical Swine Fever Virus/isolation & purification , Picornaviridae/genetics , Picornaviridae/isolation & purification , RNA, Viral/analysis , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Specimen Handling , Swine , Temperature , Transfection
16.
Nature ; 405(6784): 354-60, 2000 May 18.
Article in English | MEDLINE | ID: mdl-10830965

ABSTRACT

The receptor for advanced glycation end products (RAGE), a multi-ligand member of the immunoglobulin superfamily of cell surface molecules, interacts with distinct molecules implicated in homeostasis, development and inflammation, and certain diseases such as diabetes and Alzheimer's disease. Engagement of RAGE by a ligand triggers activation of key cell signalling pathways, such as p21ras, MAP kinases, NF-kappaB and cdc42/rac, thereby reprogramming cellular properties. RAGE is a central cell surface receptor for amphoterin, a polypeptide linked to outgrowth of cultured cortical neurons derived from developing brain. Indeed, the co-localization of RAGE and amphoterin at the leading edge of advancing neurites indicated their potential contribution to cellular migration, and in pathologies such as tumour invasion. Here we demonstrate that blockade of RAGE-amphoterin decreased growth and metastases of both implanted tumours and tumours developing spontaneously in susceptible mice. Inhibition of the RAGE-amphoterin interaction suppressed activation of p44/p42, p38 and SAP/JNK MAP kinases; molecular effector mechanisms importantly linked to tumour proliferation, invasion and expression of matrix metalloproteinases.


Subject(s)
Carrier Proteins/physiology , High Mobility Group Proteins/physiology , MAP Kinase Signaling System , Neoplasm Invasiveness , Neoplasm Metastasis , Receptors, Immunologic/physiology , Animals , Bromodeoxyuridine/metabolism , Carrier Proteins/antagonists & inhibitors , HMGB1 Protein , High Mobility Group Proteins/antagonists & inhibitors , Mice , Mice, Inbred C57BL , Mice, Nude , Mice, SCID , Neoplasm Transplantation , Rats , Receptor for Advanced Glycation End Products , Receptors, Immunologic/antagonists & inhibitors , Receptors, Immunologic/genetics , Transfection , Tumor Cells, Cultured
17.
Vet Microbiol ; 73(2-3): 159-74, 2000 Apr 13.
Article in English | MEDLINE | ID: mdl-10785325

ABSTRACT

Six laboratories participated in an exercise to compare the sensitivity and specificity of RT-PCR tests for the detection of classical swine fever virus (CSFV). Two sets of coded samples were prepared by serial dilution of positive samples and then distributed to each of the laboratories. One set comprised 34 samples of random primed cDNA. These had been synthesised from viral RNA representative of seven different genetic subtypes of CSFV. The other set comprised 40 clinical samples containing tonsil, spleen, whole blood or serum from a pig that had been experimentally infected with CSFV. Each laboratory tested the samples using one or more PCR/RT-PCR tests that they were accustomed to using. The methods and results of the laboratories were compared with one another. The RT-PCR results obtained from testing the clinical samples were also compared with those obtained by virus isolation and antigen ELISA.ELISA. Both RT-PCR and RT-nested PCR appeared to give some false positive results. Several of the PCR tests appear suitable in terms of specificity and sensitivity. Further trials are necessary to compare results when the same test is performed by different laboratories, and to show that improved control procedures can eliminate problems due to false positive reactions.A limited comparison of extraction and reverse transcription procedures showed similar results in each of three participating laboratories, even though the methods were not standardised.


Subject(s)
Classical Swine Fever Virus/isolation & purification , Polymerase Chain Reaction/veterinary , DNA, Viral/analysis , Enzyme-Linked Immunosorbent Assay/veterinary , Laboratories/standards , Polymerase Chain Reaction/methods , Polymerase Chain Reaction/standards , Sensitivity and Specificity
18.
Z Gastroenterol ; 38(2): 153-7, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10721170

ABSTRACT

The efficacy of oxaliplatin combined with high-dose 5-fluorouracil (5-FU) and folinic acid (FA) as an outpatient salvage treatment for patients with metastasized colorectal cancer was retrospectively analyzed in one center. Tumor progression had occurred for the majority of patients during two regimens (n = 11) otherwise during one (n = 1) regimen of prior 5-FU-based chemotherapy, which had been applied in a standardized sequential fashion. As third-line therapy oxaliplatin was infused intravenously over 2 h at a dose of 60 mg/m2 prior to a 2-h infusion of FA (500 mg/m2). 5-FU (2,600 mg/m2) was subsequently given over 24 h. A favorable response was observed in 9/12 (75%) of the heavily pretreated patients, including partial remissions in 3/12, minor responses in 2/12 and stable disease in 4/12 patients. The median progression free time was 23 weeks (interquartile range i. r. 0-28) for all patients, the median survival time from start of third-line therapy 55 weeks (i. r. 40-86). The median survival time from the beginning of first-line palliative chemotherapy was 34 months (i. r. 25-45 months). The highest toxicity was WHO grade III and was observed in six patients: Nausea (2), diarrhea (3), vomiting (2) and peripheral neuropathy (1). The quality of life was not adversely affected by the oxaliplatin/5-FU/FA-regimen as assessed by the EORTC QLQ-C30 questionnaire. Thus, the results show the efficiency and low toxicity of oxaliplatin/high-dose 5-FU/FA as palliative third-line therapy of patients with metastasized colorectal cancer and emphasize that sequential palliative chemotherapy may lead to extended survival of these patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Colorectal Neoplasms/drug therapy , Salvage Therapy , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Colorectal Neoplasms/mortality , Colorectal Neoplasms/pathology , Disease-Free Survival , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Fluorouracil/administration & dosage , Fluorouracil/adverse effects , Humans , Infusions, Intravenous , Leucovorin/administration & dosage , Leucovorin/adverse effects , Male , Middle Aged , Neoplasm Staging , Organoplatinum Compounds/administration & dosage , Organoplatinum Compounds/adverse effects , Oxaliplatin , Palliative Care , Retrospective Studies
19.
Avian Pathol ; 29(2): 143-52, 2000 Apr.
Article in English | MEDLINE | ID: mdl-19184800

ABSTRACT

Newcastle disease (ND) is a highly contagious avian disease. Rapid diagnosis of ND plays an important role in controlling outbreaks. Until now, time-consuming isolation of ND virus (NDV) in embryonated chicken eggs was used for NDV detection. For rapid diagnosis, reverse transcription-polymerase chain reaction (RT-PCR) with RNA extracted from tissue samples and faeces originating from experimentally and contact-infected chickens was established. Conjunctiva, lung, caecal tonsil and kidney proved to be the most suitable organs. In infected animals, NDV was detected most frequently between day 4 and 6 post-infection. Contact-infected animals gave most positive results between day 6 and 13 after exposure. RT-PCR was also able to reproducibly detect NDV in faecal samples. The RT-PCR did not show any cross-reactivity with other avian paramyxovirus serotypes, and additionally offers the possibility of subsequent sequencing of the amplified DNA allowing pathotyping of the isolate.

20.
Arch Virol ; 144(9): 1669-77, 1999.
Article in English | MEDLINE | ID: mdl-10542017

ABSTRACT

Phylogenetic analyses of large numbers of classical swine fever strains have revealed a high degree of sequence conservation in the genomic regions examined, suggesting either a recent common ancestor or a low evolution rate. This low variability is in contrast to findings with other RNA viruses. To investigate the consequence of this apparent genetic stability on phylogenetic examinations, the Belgian field isolate Wingene'93 was passaged in pigs as well as in cell culture by various methods. Sequence analyses of viruses collected after various passages in three target regions proposed for phylogenetic studies (5' NTR, E2, and NS5B) revealed a complete sequence conservation. Only when the amount of passaged virus was lowered, mimicking a genetic bottleneck, a single point mutation was observed in the E2 gene. Additionally, only four nucleotide substitutions were observed when the genome of a virus obtained after 96 cell passages in persistently infected cells was compared with its parental virus, the recombinant virus derived from an infectious cDNA clone of CSFV strain Alfort/187. This low mutation frequency observed both in vitro and in vivo demonstrates that classical swine fever virus is genetically stable. Hence, even minor mutations can be considered significant in molecular epidemiological studies.


Subject(s)
Classical Swine Fever Virus/growth & development , Classical Swine Fever Virus/genetics , Classical Swine Fever/virology , Conserved Sequence , Genetic Variation , Genome, Viral , Animals , Base Sequence , Cell Line , Classical Swine Fever Virus/isolation & purification , DNA, Complementary/genetics , Phylogeny , RNA, Viral/blood , RNA, Viral/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...